Key terms

About ARWR

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ARWR news

Today 11:16am ET Bank of America Securities Sticks to Its Buy Rating for Arrowhead Pharmaceuticals (ARWR) Today 8:04am ET Piper Sandler Keeps Their Buy Rating on Arrowhead Pharmaceuticals (ARWR) Today 6:40am ET RBC Capital Sticks to Its Buy Rating for Arrowhead Pharmaceuticals (ARWR) May 03 8:17am ET Piper Sandler Remains a Buy on Arrowhead Pharmaceuticals (ARWR) May 02 4:05pm ET Arrowhead earns $50M milestone from Royalty Pharma Apr 30 6:53am ET Biotech Sector: M&A Fuels Renewed Excitement Apr 24 7:38am ET Arrowhead begins Phase 1/2a study of ARO-CFB for mediated kidney disease Apr 15 7:03am ET Athira Pharma appoints Javier San Martin as Chief Medical Officer Apr 08 6:37am ET Arrowhead Pharmaceuticals (ARWR) Receives a Buy from Piper Sandler Apr 07 9:12am ET Arrowhead announces new Phase 2 SHASTA-2 study of plozasiran in SHTG Mar 25 8:06am ET Arrowhead begins EAP to avail plozasiran outside of trials for patients with FCS Mar 14 6:40am ET Analysts’ Top Healthcare Picks: Edwards Lifesciences (EW), Arrowhead Pharmaceuticals (ARWR) Mar 08 5:58pm ET Arrowhead CFO Myszkowski sells 40,000 common shares Mar 08 7:35am ET Arrowhead doses first patients in ARO-DM1 trial Feb 28 1:28pm ET Arrowhead rumor mentioned in Betaville blog Feb 22 6:22am ET Arrowhead Pharmaceuticals Appoints Dr. Hongbo Lu to Board

No recent press releases are available for ARWR

ARWR Financials

1-year income & revenue

Key terms

ARWR Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ARWR Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms